Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Longwood Biopharmaceuticals Co., Ltd.

Clinical trials sponsored by Shanghai Longwood Biopharmaceuticals Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hepatitis b drug enters human trials – could it help control the virus? Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Completed 3

New pill aims to restore skin color in vitiligo patients

Disease control Not yet recruiting

This study tests an experimental pill called LW402 in 180 adults with non-segmental vitiligo, a condition that causes white patches on the skin. The pill works by blocking certain immune signals. Participants will take one of three doses or a placebo for up to 52 weeks to see if …

Phase 2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:25 UTC